128 related articles for article (PubMed ID: 20962262)
21. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3.
Workman CJ; Dugger KJ; Vignali DA
J Immunol; 2002 Nov; 169(10):5392-5. PubMed ID: 12421911
[TBL] [Abstract][Full Text] [Related]
22. Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.
Leung CS; Maurer MA; Meixlsperger S; Lippmann A; Cheong C; Zuo J; Haigh TA; Taylor GS; Münz C
Blood; 2013 Feb; 121(9):1584-94. PubMed ID: 23297134
[TBL] [Abstract][Full Text] [Related]
23. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.
Schreibelt G; Klinkenberg LJ; Cruz LJ; Tacken PJ; Tel J; Kreutz M; Adema GJ; Brown GD; Figdor CG; de Vries IJ
Blood; 2012 Mar; 119(10):2284-92. PubMed ID: 22234694
[TBL] [Abstract][Full Text] [Related]
24. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J
Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893
[TBL] [Abstract][Full Text] [Related]
25. Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells.
Meyer zum Bueschenfelde CO; Unternaehrer J; Mellman I; Bottomly K
J Immunol; 2004 Nov; 173(10):6119-24. PubMed ID: 15528348
[TBL] [Abstract][Full Text] [Related]
26. LAG-3 inhibits the activation of CD4
Maruhashi T; Okazaki IM; Sugiura D; Takahashi S; Maeda TK; Shimizu K; Okazaki T
Nat Immunol; 2018 Dec; 19(12):1415-1426. PubMed ID: 30349037
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
[TBL] [Abstract][Full Text] [Related]
28. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
29. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
Germain RN
Cell; 1994 Jan; 76(2):287-99. PubMed ID: 8293464
[No Abstract] [Full Text] [Related]
30. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
Mukhopadhyay S; Peiser L; Gordon S
J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal age related change in natural killer cell receptors for MHC class I.
Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
[TBL] [Abstract][Full Text] [Related]
32. Developmental dissociation of T cells from B, NK, and myeloid cells revealed by MHC class II-specific chimeric immune receptors bearing TCR-zeta or FcR-gamma chain signaling domains.
Lin WY; Roberts MR
Blood; 2002 Oct; 100(8):3045-8. PubMed ID: 12351421
[TBL] [Abstract][Full Text] [Related]
33. SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.
Detre C; Keszei M; Romero X; Tsokos GC; Terhorst C
Semin Immunopathol; 2010 Jun; 32(2):157-71. PubMed ID: 20146065
[TBL] [Abstract][Full Text] [Related]
34. Dominant tolerance to kidney allografts induced by anti-donor MHC class II antibodies: cooperation between T and non-T CD103+ cells.
Degauque N; Lair D; Dupont A; Moreau A; Roussey G; Moizant F; Hubert FX; Louvet C; Hill M; Haspot F; Josien R; Usal C; Vanhove B; Soulillou JP; Brouard S
J Immunol; 2006 Apr; 176(7):3915-22. PubMed ID: 16547225
[TBL] [Abstract][Full Text] [Related]
35. Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes.
Siemasko K; Eisfelder BJ; Williamson E; Kabak S; Clark MR
J Immunol; 1998 Jun; 160(11):5203-8. PubMed ID: 9605114
[TBL] [Abstract][Full Text] [Related]
36. Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination.
Reuter A; Panozza SE; Macri C; Dumont C; Li J; Liu H; Segura E; Vega-Ramos J; Gupta N; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
J Immunol; 2015 Mar; 194(6):2696-705. PubMed ID: 25653426
[TBL] [Abstract][Full Text] [Related]
37. A secreted form of the major histocompatibility complex class II-associated invariant chain inhibiting T cell activation.
Eynon EE; Schlax C; Pieters J
J Biol Chem; 1999 Sep; 274(37):26266-71. PubMed ID: 10473581
[TBL] [Abstract][Full Text] [Related]
38. How many thymocytes audition for selection?
Merkenschlager M; Graf D; Lovatt M; Bommhardt U; Zamoyska R; Fisher AG
J Exp Med; 1997 Oct; 186(7):1149-58. PubMed ID: 9314563
[TBL] [Abstract][Full Text] [Related]
39. Primary MHC-class II(+) cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate.
Soriano-Sarabia N; Sandvold H; Jomaa H; Kubin T; Bein G; Hackstein H
J Immunol; 2012 Dec; 189(11):5212-22. PubMed ID: 23105138
[TBL] [Abstract][Full Text] [Related]
40. Differential antigen processing by dendritic cell subsets in vivo.
Dudziak D; Kamphorst AO; Heidkamp GF; Buchholz VR; Trumpfheller C; Yamazaki S; Cheong C; Liu K; Lee HW; Park CG; Steinman RM; Nussenzweig MC
Science; 2007 Jan; 315(5808):107-11. PubMed ID: 17204652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
